Maiwald Magazine

Press Coverage

5 Dec 2025 - Press Coverage

Royalty Pharma and Denali Therapeutics Announce $275 Million Royalty Funding Agreement.

Royalty Pharma and Denali have entered into a $275 million financing agreement which, pursuant to a synthetic royalty agreement, is based on future net sales of tividenofusp alfa. Tividenofusp alfa is Denali’s lead investigational TransportVehicle™-enabled enzyme rep...

25 Aug 2025 - Press Coverage

Royalty Pharma acquires licence interest for Amgen’s Imdelltra – Maiwald advises on transaction

Royalty Pharma has acquired a royalty interest in Amgen's Imdelltra, an innovative BiTE antibody for the treatment of small cell lung cancer, from BeOne Medicines for an upfront payment of $885 million. The agreement allows BeOne to sell additional royalty rights in Imdelltr...

14 Jul 2025 - Press Coverage

Royalty Pharma and Revolution Medicines Sign Funding Agreements Worth Up to $2 Billion

Royalty Pharma plc and Revolution Medicines, Inc. have announced a strategic funding collaboration of up to $2 billion to support the global development and commercialization of Revolution’s RAS(ON) inhibitor portfolio, particularly the clinical advancement of lead candida...

Maiwald in the press

Publications

11 Feb 2026 - Publication

EU provisionally approves framework for new genomic technique plants from 2028

EU member states and the European Parliament have provisionally agreed a new regulatory framework for plants produced by new genomic techniques (NGTs). The deal creates two pa...

10 Feb 2026 - Publication

KI-Compliance: Zur Wechselwirkung von Sorgfaltsmaßstab und Vertrauensschutz beim Einsatz von ChatGPT – Vertrauen schützen, Sorgfalt wahren, Betriebs-Berater, 45/2025, (Article in german)

With the AI Act, the EU legislator has set out to establish a legal framework for trustworthy AI. However, a harmonized EU-level regime on AI liability is, for the time being,...

29 Jan 2026 - Publication

Patenting artificial intelligence

All publications

Events

Thu.

5 Mar 2026 |Upcoming

Maiwald invites you to the MAItalk in Munich

On March 5 2026, we warmly invite you to the MAItalk seminar at our Munich office. Look forward to engaging, practice‑oriented presentations and stimulating discussions in a collegial atmosphere - ideal for exchanging ideas with experts and peers. Catering will be provided throughout the event.

Tue.

10 Mar 2026 |Upcoming

2nd European Summit for Women Leaders in Life Science Law

Maiwald will once again participate in the “European Summit for Women Leaders in Life Sciences Law” in Brussels in 2026 and is looking forward to engaging with international experts from across the life sciences legal community. The conference offers practical insights into current legal and regulatory developments i...

Wed.

8 Apr 2026 |Upcoming

Maiwald at the 33rd Annual IP Conference of the Fordham IP Institute in New York

The 33rd Annual IP Law & Policy Conference of the renowned Fordham Intellectual Property Institute will take place from 8 to 10 April 2026 at Fordham Law School in New York. This event brings together leaders from government, the judiciary, academia and business worldwide to discuss current challenges in intellectual property.

Sun.

26 Apr 2026 |Upcoming

LESI 2026 Annual Conference in Dublin | April 26th-29th

Maiwald will once again participate in the LESI Annual Conference in 2026. “LESI 2026 – INNOVATION TO IMPACT: IP as an International Growth Engine” will take place on 26–29 April and will bring together leading minds and decision-makers in Dublin to showcase how intellectual property serves as an...

All events

News and Releases

Maiwald Blog

New fee schedule for the Unified Patent Court (UPC) from 1 January 2026

Why Patent Defense and Military Technologies?

Turn one into several – what Rule 80 EPC says about using several independent claims to defend one independent claim

Press Coverage

Royalty Pharma and Denali Therapeutics Announce $275 Million Royalty Funding Agreement.

Royalty Pharma acquires licence interest for Amgen’s Imdelltra – Maiwald advises on transaction

Royalty Pharma and Revolution Medicines Sign Funding Agreements Worth Up to $2 Billion

Staff News

Maiwald appoints Martina Boidol, Dr. Anja Fux, and Sebastian Herzog as managing partners

Dr Iris Müller and Dr Gabriel Kiefl sworn in as German patent attorneys

Marvin Bäumel sworn in as German patent attorney

Publications

EU provisionally approves framework for new genomic technique plants from 2028

KI-Compliance: Zur Wechselwirkung von Sorgfaltsmaßstab und Vertrauensschutz beim Einsatz von ChatGPT – Vertrauen schützen, Sorgfalt wahren, Betriebs-Berater, 45/2025, (Article in german)

Patenting artificial intelligence

Awards

Chambers Germany 2026 Rankings

Managing IP EMEA Awards 2026: shortlists revealed

The Legal 500 Germany 2026

Events

Maiwald invites you to the MAItalk in Munich

2nd European Summit for Women Leaders in Life Science Law

Maiwald at the 33rd Annual IP Conference of the Fordham IP Institute in New York

LESI 2026 Annual Conference in Dublin | April 26th-29th